|
18
|
222
|
7s07X |
Crystal structure of epstein-barr virus glycoprotein gh/gl/gp42-peptide in complex with human neutralizing antibodies 769b10 and 769c2 |
|
16
|
98
|
7s07B |
Crystal structure of epstein-barr virus glycoprotein gh/gl/gp42-peptide in complex with human neutralizing antibodies 769b10 and 769c2 |
|
32
|
214
|
7s07L |
Crystal structure of epstein-barr virus glycoprotein gh/gl/gp42-peptide in complex with human neutralizing antibodies 769b10 and 769c2 |
|
19
|
212
|
7s07Y |
Crystal structure of epstein-barr virus glycoprotein gh/gl/gp42-peptide in complex with human neutralizing antibodies 769b10 and 769c2 |
|
32
|
230
|
7s07H |
Crystal structure of epstein-barr virus glycoprotein gh/gl/gp42-peptide in complex with human neutralizing antibodies 769b10 and 769c2 |
|
49
|
223
|
7sscH |
Trl345 lineage ancestor i8 fab bound to an hcmv gb-derived peptide |
|
50
|
214
|
7sscL |
Trl345 lineage ancestor i8 fab bound to an hcmv gb-derived peptide |
|
47
|
209
|
7xxlC |
Rbd in complex with fab14 |
|
37
|
195
|
7xxlB |
Rbd in complex with fab14 |
|
47
|
229
|
7xxlA |
Rbd in complex with fab14 |
|
15
|
105
|
7yadB |
Cryo-em structure of s309-rbd-rbd-s309 in the s309-bound omicron spike protein (local refinement) |
|
20
|
124
|
7yadA |
Cryo-em structure of s309-rbd-rbd-s309 in the s309-bound omicron spike protein (local refinement) |
|
17
|
185
|
7yadE |
Cryo-em structure of s309-rbd-rbd-s309 in the s309-bound omicron spike protein (local refinement) |
|
41
|
194
|
7t7bA |
Crystal structure of sars-cov-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody adi-62113 fab |
|
47
|
210
|
7t7bL |
Crystal structure of sars-cov-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody adi-62113 fab |
|
38
|
230
|
7t7bH |
Crystal structure of sars-cov-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody adi-62113 fab |
|
14
|
111
|
7wp0L |
Cryo-em structure of sars-cov-2 delta s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
17
|
183
|
7wp0F |
Cryo-em structure of sars-cov-2 delta s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
14
|
131
|
7wp2H |
Cryo-em structure of sars-cov-2 c.1.2 s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
18
|
109
|
7wp2L |
Cryo-em structure of sars-cov-2 c.1.2 s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
21
|
182
|
7wp2F |
Cryo-em structure of sars-cov-2 c.1.2 s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
17
|
131
|
7wp0H |
Cryo-em structure of sars-cov-2 delta s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
13
|
131
|
7wp1H |
Cryo-em structure of sars-cov-2 mu s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
12
|
109
|
7wp1L |
Cryo-em structure of sars-cov-2 mu s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
15
|
131
|
7wp5H |
Cryo-em structure of sars-cov-2 omicron s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
15
|
183
|
7wp5F |
Cryo-em structure of sars-cov-2 omicron s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
16
|
183
|
7wp1F |
Cryo-em structure of sars-cov-2 mu s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
12
|
111
|
7wp5L |
Cryo-em structure of sars-cov-2 omicron s6p trimer in complex with neutralizing antibody vacw-209 (local refinement) |
|
51
|
172
|
7l0lB |
Cryo-em structure of the vrc316 clinical trial, vaccine-elicited, human antibody 316-310-1b11 in complex with an h2 can05 ha trimer |
|
17
|
108
|
7l0lJ |
Cryo-em structure of the vrc316 clinical trial, vaccine-elicited, human antibody 316-310-1b11 in complex with an h2 can05 ha trimer |
|
63
|
322
|
7l0lA |
Cryo-em structure of the vrc316 clinical trial, vaccine-elicited, human antibody 316-310-1b11 in complex with an h2 can05 ha trimer |
|
18
|
120
|
7l0lG |
Cryo-em structure of the vrc316 clinical trial, vaccine-elicited, human antibody 316-310-1b11 in complex with an h2 can05 ha trimer |
|
28
|
198
|
7n6eG |
Tcr peptide hla-a2 complex |
|
49
|
219
|
7n3iH |
Crystal structure of the sars-cov-2 receptor binding domain in complex with the human neutralizing antibody fab fragment c098 |
|
50
|
213
|
7n3iL |
Crystal structure of the sars-cov-2 receptor binding domain in complex with the human neutralizing antibody fab fragment c098 |
|
47
|
216
|
7mmnE |
Crystal structure of the prefusion rsv f glycoprotein bound by human antibody am14 |
|
20
|
213
|
7mlzL |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
84
|
373
|
7mmnB |
Crystal structure of the prefusion rsv f glycoprotein bound by human antibody am14 |
|
11
|
122
|
7mm0H |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
20
|
222
|
7mlzH |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
180
|
1136
|
7mm0A |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
10
|
107
|
7mm0L |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
11
|
72
|
7mmnA |
Crystal structure of the prefusion rsv f glycoprotein bound by human antibody am14 |
|
44
|
222
|
7mmnD |
Crystal structure of the prefusion rsv f glycoprotein bound by human antibody am14 |
|
61
|
274
|
7n6eA |
Tcr peptide hla-a2 complex |
|
14
|
99
|
7n6dB |
Hla peptide complex |
|
12
|
99
|
7n6eB |
Tcr peptide hla-a2 complex |
|
75
|
275
|
7n6dA |
Hla peptide complex |
|
49
|
239
|
7n6eH |
Tcr peptide hla-a2 complex |
|
20
|
196
|
7mlzA |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
